Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Am J Physiol Gastrointest Liver Physiol
2007 Nov 01;2935:G1046-53. doi: 10.1152/ajpgi.00233.2007.
Show Gene links
Show Anatomy links
Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+).
Srinivas SR
,
Prasad PD
,
Umapathy NS
,
Ganapathy V
,
Shekhawat PS
.
???displayArticle.abstract???
L-carnitine is absorbed in the intestinal tract via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+). Loss-of-function mutations in OCTN2 may be associated with inflammatory bowel disease (IBD), suggesting a role for carnitine in intestinal/colonic health. In contrast, ATB(0,+) is upregulated in bowel inflammation. Butyrate, a bacterial fermentation product, is beneficial for prevention/treatment of ulcerative colitis. Butyryl-L-carnitine (BC), a butyrate ester of carnitine, may have potential for treatment of gut inflammation, since BC would supply both butyrate and carnitine. We examined the transport of BC via ATB(0,+) to determine if this transporter could serve as a delivery system for BC. We also examined the transport of BC via OCTN2. Studies were done with cloned ATB(0,+) and OCTN2 in heterologous expression systems. BC inhibited ATB(0,+)-mediated glycine transport in mammalian cells (IC(50), 4.6 +/- 0.7 mM). In Xenopus laevis oocytes expressing human ATB(0,+), BC induced Na(+) -dependent inward currents under voltage-clamp conditions. The currents were saturable with a K(0.5) of 1.4 +/- 0.1 mM. Na(+) activation kinetics of BC-induced currents suggested involvement of two Na(+) per transport cycle. BC also inhibited OCTN2-mediated carnitine uptake (IC(50), 1.5 +/- 0.3 microM). Transport of BC via OCTN2 is electrogenic, as evidenced from BC-induced inward currents. These currents were Na(+) dependent and saturable (K(0.5), 0.40 +/- 0.02 microM). We conclude that ATB(0,+) is a low-affinity/high-capacity transporter for BC, whereas OCTN2 is a high-affinity/low-capacity transporter. ATB(0,+) may mediate intestinal absorption of BC when OCTN2 is defective.
Bennett,
Inborn errors of mitochondrial fatty acid oxidation.
2000, Pubmed
Bennett,
Inborn errors of mitochondrial fatty acid oxidation.
2000,
Pubmed
Brown,
The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids.
2003,
Pubmed
,
Xenbase
Buyse,
Luminal leptin enhances CD147/MCT-1-mediated uptake of butyrate in the human intestinal cell line Caco2-BBE.
2002,
Pubmed
Canani,
Butyrate as an effective treatment of congenital chloride diarrhea.
2004,
Pubmed
Cavaglieri,
Differential effects of short-chain fatty acids on proliferation and production of pro- and anti-inflammatory cytokines by cultured lymphocytes.
2003,
Pubmed
Cederbaum,
Carnitine membrane transporter deficiency: a long-term follow up and OCTN2 mutation in the first documented case of primary carnitine deficiency.
2002,
Pubmed
Cetinkaya,
Effects of L-carnitine on oxidant/antioxidant status in acetic acid-induced colitis.
2006,
Pubmed
D'Argenio,
Experimental colitis: decreased Octn2 and Atb0+ expression in rat colonocytes induces carnitine depletion that is reversible by carnitine-loaded liposomes.
2006,
Pubmed
Dass,
The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPR43 receptor activation.
2007,
Pubmed
Durán,
Functional characterization of intestinal L-carnitine transport.
2002,
Pubmed
Elimrani,
Expression and localization of organic cation/carnitine transporter OCTN2 in Caco-2 cells.
2003,
Pubmed
Fei,
Primary structure, genomic organization, and functional and electrogenic characteristics of human system N 1, a Na+- and H+-coupled glutamine transporter.
2000,
Pubmed
,
Xenbase
Ferraris,
Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases: an Italian multicentric study.
2006,
Pubmed
Fisher,
Direct or indirect association in a complex disease: the role of SLC22A4 and SLC22A5 functional variants in Crohn disease.
2006,
Pubmed
García-Miranda,
Developmental maturation and segmental distribution of rat small intestinal L-carnitine uptake.
2005,
Pubmed
Gasbarrini,
Effects of propionyl-L-carnitine topical irrigation in distal ulcerative colitis: a preliminary report.
2003,
Pubmed
Gazouli,
Single nucleotide polymorphisms of OCTN1, OCTN2, and DLG5 genes in Greek patients with Crohn's disease.
2005,
Pubmed
Giancaterini,
Effects of propyonil-l-carnitine topical irrigation in distal ulcerative colitis: a preliminary report.
2001,
Pubmed
Gill,
Expression and membrane localization of MCT isoforms along the length of the human intestine.
2005,
Pubmed
Gopal,
Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract.
2007,
Pubmed
,
Xenbase
Gupta,
SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter.
2006,
Pubmed
Hatanaka,
Transport of amino acid-based prodrugs by the Na+- and Cl(-) -coupled amino acid transporter ATB0,+ and expression of the transporter in tissues amenable for drug delivery.
2004,
Pubmed
,
Xenbase
Heimerl,
Alterations in intestinal fatty acid metabolism in inflammatory bowel disease.
2006,
Pubmed
Karaki,
Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine.
2006,
Pubmed
Kato,
Organic cation/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse.
2006,
Pubmed
Kinoshita,
Butyrate reduces colonic paracellular permeability by enhancing PPARgamma activation.
2002,
Pubmed
Koizumi,
Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency.
1999,
Pubmed
Le Poul,
Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation.
2003,
Pubmed
Leung,
Polymorphisms in the organic cation transporter genes SLC22A4 and SLC22A5 and Crohn's disease in a New Zealand Caucasian cohort.
2006,
Pubmed
Martínez,
Association of the organic cation transporter OCTN genes with Crohn's disease in the Spanish population.
2006,
Pubmed
Matthews,
Na-K-2Cl cotransporter gene expression and function during enterocyte differentiation. Modulation of Cl- secretory capacity by butyrate.
1998,
Pubmed
Miller,
Cellular and physiological effects of short-chain fatty acids.
2004,
Pubmed
Miyauchi,
Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na(+)-coupled transporter for short-chain fatty acids.
2004,
Pubmed
,
Xenbase
Nakanishi,
Na+- and Cl--coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytes.
2001,
Pubmed
,
Xenbase
Newman,
A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease.
2005,
Pubmed
Noble,
The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease.
2005,
Pubmed
Palmieri,
Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis.
2006,
Pubmed
Peltekova,
Functional variants of OCTN cation transporter genes are associated with Crohn disease.
2004,
Pubmed
Ramakrishna,
The effects of enterotoxins and short-chain fatty acids on water and electrolyte fluxes in ileal and colonic loops in vivo in the rat.
1990,
Pubmed
Rinaldo,
Fatty acid transport and mitochondrial oxidation disorders.
2001,
Pubmed
Rinaldo,
Fatty acid oxidation disorders.
2002,
Pubmed
Rinaldo,
Clinical and biochemical features of fatty acid oxidation disorders.
1998,
Pubmed
Roediger,
Metabolic induction of experimental ulcerative colitis by inhibition of fatty acid oxidation.
1986,
Pubmed
Roediger,
Selective reduction of fatty acid oxidation in colonocytes: correlation with ulcerative colitis.
1990,
Pubmed
Russell,
Analysis of the influence of OCTN1/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease.
2006,
Pubmed
Scheppach,
The butyrate story: old wine in new bottles?
2004,
Pubmed
Seth,
Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function.
1999,
Pubmed
Shekhawat,
Spontaneous development of intestinal and colonic atrophy and inflammation in the carnitine-deficient jvs (OCTN2(-/-)) mice.
2007,
Pubmed
Shekhawat,
Human placenta metabolizes fatty acids: implications for fetal fatty acid oxidation disorders and maternal liver diseases.
2003,
Pubmed
Spiekerkoetter,
Silent and symptomatic primary carnitine deficiency within the same family due to identical mutations in the organic cation/carnitine transporter OCTN2.
2003,
Pubmed
Sundaram,
Neutral Na-amino acid cotransport is differentially regulated by glucocorticoids in the normal and chronically inflamed rabbit small intestine.
2007,
Pubmed
Tong,
Butyrate suppresses Cox-2 activation in colon cancer cells through HDAC inhibition.
2004,
Pubmed
Törkvist,
Contribution of the IBD5 locus to Crohn's disease in the Swedish population.
2007,
Pubmed
Török,
Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease.
2005,
Pubmed
Vermeire,
Current status of genetics research in inflammatory bowel disease.
2005,
Pubmed
Vermeire,
Association of organic cation transporter risk haplotype with perianal penetrating Crohn's disease but not with susceptibility to IBD.
2005,
Pubmed
Wagner,
Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2.
2000,
Pubmed
,
Xenbase
Waller,
Evidence for association of OCTN genes and IBD5 with ulcerative colitis.
2006,
Pubmed
Wang,
A missense mutation in the OCTN2 gene associated with residual carnitine transport activity.
2000,
Pubmed
Wang,
Mutations in the organic cation/carnitine transporter OCTN2 in primary carnitine deficiency.
1999,
Pubmed
Wilcken,
Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry.
2001,
Pubmed
Wu,
cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family.
1998,
Pubmed
Wu,
Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter.
1999,
Pubmed
Xiong,
Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41.
2004,
Pubmed
,
Xenbase
Yamazaki,
Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease.
2004,
Pubmed
Yokogawa,
Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice.
1999,
Pubmed
